Cardiovascular Systems - Stock Price History | CSII

Historical daily share price chart and data for Cardiovascular Systems since 2020 adjusted for splits. The latest closing stock price for Cardiovascular Systems as of September 22, 2020 is 35.19.
  • The all-time high Cardiovascular Systems stock closing price was 104.00 on August 08, 2006.
  • The Cardiovascular Systems 52-week high stock price is 55.22, which is 56.9% above the current share price.
  • The Cardiovascular Systems 52-week low stock price is 26.00, which is 26.1% below the current share price.
  • The average Cardiovascular Systems stock price for the last 52 weeks is 39.47.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cardiovascular Systems Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 41.4054 28.3300 52.2000 26.7400 48.5900 70.55%
2018 30.1094 24.2400 39.2500 21.0500 28.4900 20.26%
2017 28.1704 24.1100 32.8900 23.3650 23.6900 -2.15%
2016 18.1133 14.5800 27.1400 7.6700 24.2100 60.12%
2015 26.5858 29.5600 40.9800 13.5400 15.1200 -49.73%
2014 29.6898 33.2400 36.5900 23.6300 30.0800 -12.28%
2013 21.4619 12.9800 34.2900 12.9800 34.2900 173.23%
2012 10.0472 10.1500 12.8900 8.2800 12.5500 27.41%
2011 11.6191 11.7700 16.1000 7.4100 9.8500 -15.52%
2010 5.7042 4.5900 11.7500 3.8500 11.6600 154.03%
2009 7.1025 9.5000 10.3000 3.8400 4.5900 -50.65%
2008 13.9449 30.2000 30.2000 3.5000 9.3000 -70.00%
2007 54.2741 56.5000 70.0000 31.0000 31.0000 -45.99%
2006 83.9558 101.0000 104.0000 51.9000 57.4000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.367B $0.237B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $187.588B 35.20
Medtronic (MDT) Ireland $140.874B 26.53
Stryker (SYK) United States $76.056B 29.49
Boston Scientific (BSX) United States $55.153B 31.86
Lonza Group Ag (LZAGY) Switzerland $46.893B 0.00
Baxter (BAX) United States $40.625B 24.85
Terumo (TRUMY) Japan $30.404B 38.86
EssilorLuxottica Societe Anonyme (ESLOY) France $28.134B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.745B 23.02
ResMed (RMD) United States $24.852B 36.03
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.462B 0.00
Bio-Rad Laboratories (BIO) United States $15.371B 69.52
Insulet (PODD) United States $14.743B 623.81
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.390B 44.44
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.267B 10.75
Canopy Growth (CGC) Canada $5.852B 0.00
Hill-Rom Holdings (HRC) United States $5.626B 13.96
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.515B 0.00
Haemonetics (HAE) United States $4.236B 28.23
ICU Medical (ICUI) United States $4.018B 30.66
Neogen (NEOG) United States $3.955B 65.99
Envista Holdings (NVST) United States $3.743B 25.52
Abcam (ABCZY) $3.232B 0.00
TG Therapeutics (TGTX) United States $3.227B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.107B 0.00
National Vision Holdings (EYE) United States $3.004B 466.88
NuVasive (NUVA) United States $2.537B 35.36
Agios Pharmaceuticals (AGIO) United States $2.521B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.901B 173.46
AtriCure (ATRC) United States $1.737B 0.00
NanoString Technologies (NSTG) United States $1.723B 0.00
MacroGenics (MGNX) United States $1.489B 0.00
Aphria (APHA) Canada $1.280B 0.00
InMode (INMD) Israel $1.113B 28.07
Cerus (CERS) United States $1.029B 0.00
Quanterix (QTRX) United States $0.941B 0.00
Owens & Minor (OMI) United States $0.906B 20.30
OraSure Technologies (OSUR) United States $0.905B 0.00
PetIQ (PETQ) United States $0.851B 24.41
BioLife Solutions (BLFS) United States $0.845B 440.00
Lantheus Holdings (LNTH) United States $0.833B 11.55
Meridian Bioscience (VIVO) United States $0.743B 17.16
Aurora Cannabis (ACB) Canada $0.730B 0.00
Phibro Animal Health (PAHC) United States $0.714B 16.35
Vapotherm (VAPO) United States $0.712B 0.00
LeMaitre Vascular (LMAT) United States $0.650B 39.68
Omeros (OMER) United States $0.636B 0.00
Zynex (ZYXI) United States $0.560B 48.91
Eagle Pharmaceuticals (EGRX) United States $0.540B 76.31
Surmodics (SRDX) United States $0.525B 57.61
VAREX IMAGING (VREX) United States $0.461B 19.99
Cytosorbents (CTSO) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.358B 12.79
HEXO (HEXO) $0.343B 0.00
Utah Medical Products (UTMD) United States $0.287B 24.64
Surface Oncology (SURF) United States $0.271B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
InfuSystems Holdings (INFU) United States $0.260B 49.54
Organigram Holdings (OGI) Canada $0.231B 0.00
Female Health (VERU) United States $0.197B 0.00
Chimerix (CMRX) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.172B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.155B 13.76
Exagen (XGN) United States $0.140B 0.00
Liberty Health Sciences (LHSIF) Canada $0.134B 0.00
Evolus (EOLS) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.102B 0.00
Rockwell Medical (RMTI) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.096B 0.00
United-Guardian (UG) United States $0.069B 15.46
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Brainsway (BWAY) Israel $0.064B 0.00
Nephros (NEPH) United States $0.057B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 9.95
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.021B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.019B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00